InVivo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NVIV and buy or sell other stocks, ETFs, and their options commission-free!About NVIV
InVivo Therapeutics Corporation is a medical device company focused on utilizing polymers as a platform technology to develop treatments to restore function in individuals paralyzed as a result of traumatic spinal cord injuries. The company was founded in 2005 on the basis of research initiated in Cambridge, Massachusetts, United States.
CEORichard Toselli, MD, MBA
CEORichard Toselli, MD, MBA
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2005
Founded2005
Employees—
Employees—
NVIV Key Statistics
Market cap1.15M
Market cap1.15M
Price-Earnings ratio-0.11
Price-Earnings ratio-0.11
Dividend yield—
Dividend yield—
Average volume11.58K
Average volume11.58K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.4348
52 Week high$0.4348
52 Week low$0.15
52 Week low$0.15
Stock Snapshot
InVivo Therapeutics(NVIV) stock is priced at $4.83, giving the company a market capitalization of 1.15M. It carries a P/E multiple of -0.11.
On 2025-12-23, InVivo Therapeutics(NVIV) stock opened at —, reached a high of —, and a low of —.
The InVivo Therapeutics(NVIV)'s current trading volume is 0, compared to an average daily volume of 11.58K.
During the past year, InVivo Therapeutics(NVIV) stock moved between $0.15 at its lowest and $0.43 at its peak.
During the past year, InVivo Therapeutics(NVIV) stock moved between $0.15 at its lowest and $0.43 at its peak.
People also own
Based on the portfolios of people who own NVIV. This list is generated using Robinhood data, and it’s not a recommendation.